Elliot Brown Consulting
Beck House, 55 Elmete Drive,
Leeds, LS8 2LA, United Kingdom
tel: 44 (0)20 8144 5617
fax: 44 (0)870 112 8196
email

Elliot Brown Consulting is a partner in a major international research project funded by the Seventh Framework Programme (FP-7) of the Research Directorate of the European Commission (EC).

"Monitoring Medicines" involves a) methodological development in direct patient reporting of suspected adverse reactions b) better analysis of reasons for medication errors c) improved approaches to active and focused medicine surveillance d) identification of early indicators of drug dependence and substandard medicines in medicine safety databases and e) decision support tools for treatment of HIV/AIDS

The partners in the project cover a wide range of organisations dedicated to improving public health through safer use of medicines; they are:

The overall aim of "Monitoring Medicines" is to strengthen what we know about medicines and their use, sharing that knowledge and putting the knowledge to use to reduce patient deaths and adverse effects due to medicines. The project will help to advance the application, co-ordination and optimal use of pharmacovigilance evidence, and to strengthen the links between the various individuals, national pharmacovigilance centres and experts involved. Most importantly, the project will strive to increase consumer involvement in the reporting of adverse drug reactions (ADRs), and mobilize and sustain political commitment to support those working in drug safety.

Founded by two globally respected experts, PrimeVigilance Ltd. provides a unique offering in the field of pharmacovigilance (PV).

PrimeVigilance specialises in helping emerging and established companies to comply with regulations, from full management of safety operations to specialist consulting. Its comprehensive services cover all the regulatory, medical and scientific elements of PV required to obtain and maintain a product licence within Europe, including:

PrimeVigilance is a multinational company, registered in the UK with bases across four continents, providing innovative, top quality, cost-effective safety operations for small and medium-sized pharmaceutical and biotechnology companies. Originally set up as a joint venture between Dr. Elliot Brown and Dr. Miroslav Reljanovic, the founder of the Ergomed Group, PrimeVigilance quickly grew to establish an international footprint and a culture of excellence and leadership.

Dr. Elliot Brown's existing consultancy has an enviable reputation of over a decade in PV, with a network of expert associates spanning three continents. These include former senior regulators and consultants with extensive industry experience. To complement this top-level, global consultancy support, the Ergomed Group brings an experienced operational dimension to the PrimeVigilance offering. With offices in the UK, Germany, Southern and Eastern Europe, Russia, the USA and the middle-East, the Ergomed Group is a quality-focused organisation with outstanding staff and many years experience with the ARISg safety database and clinical safety management.

PrimeVigilance will fill the gap between the large multinational CROs that do not provide a service geared towards post-marketing surveillance for small- and medium-sized companies, and the small service providers that do not have the critical mass, expertise or wide international presence needed to reassure that patients and products will be adequately protected.

For more details visit www.primevigilance.com or contact PrimeVigilance at....

Phone: +44 (0) 1483 688 349
Fax: +44 (0) 1483 688 348

info@primevigilance.com

Welcome to Elliot Brown Consulting - pharmacovigilance

Elliot Brown Consulting provides a dedicated pharmacovigilance resource for the international pharmaceutical and biologicals industries.

Our team of highly experienced pharmaceutical and regulatory affairs consultants and associates in 3 continents can provide expert and cost-effective solutions for:

Services include support for:

Pharmacovigilance Services

Our consultants are at the leading edge of developments in pharmacovigilance and therapeutic risk management. Elliot Brown Consulting offers a range of services including:

Elliot Brown Consulting are pleased to offer pharmacovigilance services in conjunction with PrimeVigilance, the dedicated full-service pharmacovigilance solutions provider.

 

 

 

 

Useful sites

PrimeVigilance: Pharmacovigilance outsourcing and service provider http://www.primevigilance.com
Inpharm http://www.inpharm.com
ABPI http://www.abpi.org.uk
DIA http://www.diahome.org
WHO http://www.who.ch
EU Commission http://ec.europa.eu/enterprise/pharmaceuticals/index_en.htm
ISPE http://www.pharmacoepi.org
MedDRA http://www.meddramsso.com
CSM (now CMH) Commission on Human Medicines
GPRD General Practice Research Database
NICE National Institute for Clinical Excellence
Medicines compendium Medicines.org.uk
Pharmacovigilance Information Pharmacovigilance Information

Regulatory authorities:

http://www.fda.gov
The European Medicines Agency
Austria / Federal Ministry of Labour, Health and Social Affairs
Belgium / The Directorate-General Public Health Protection
Denmark / Danish Medicines Agency
Finland / National Agency for Medicines
France / Agence Francaise de Securite Sanitaire des Produits de Sante
Germany / Federal Institute for Drugs and Medical Devices (BfArM)
Greece / National Drug Organization
Iceland / Icelandic Medicines Control Agency (MCA)
Ireland / Irish Medicines Board
Italy / Ministry of Health
Luxemburg / Division de la Farmacie et des Médicamentes
Netherlands / Medicines Evaluation Board
Norway / Norwegian Medicines Agency
Portugal / INFARMED / The National Pharmacy and Medicines Institute
Spain / Agencia Española de Medicamentos y Productos Sanitarios
Sweden / Medical Products Agency
Australia / Therapeutic Goods Administration (TGA)
Japan/ National Institute of Health Sciences, Japan
Canada / Therapeutic Products Directorate
USA / The Food and Drug Administration (FDA)
UK / MHRA
Heads of agencies

 

 

 

OTHER PAGES: